INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,221,485 | -22.5% | 544,639 | 0.0% | 4.60% | +2.8% |
Q2 2023 | $22,210,378 | +4.1% | 544,639 | -4.9% | 4.47% | -19.3% |
Q1 2023 | $21,335,547 | +34.3% | 572,459 | +25.7% | 5.54% | +34.5% |
Q4 2022 | $15,883,254 | -24.2% | 455,238 | +21.6% | 4.12% | -16.9% |
Q3 2022 | $20,952,000 | +35.2% | 374,409 | +25.0% | 4.96% | +15.3% |
Q2 2022 | $15,497,000 | +33.8% | 299,409 | +87.8% | 4.30% | +38.5% |
Q1 2022 | $11,584,000 | -39.0% | 159,409 | -0.7% | 3.11% | -10.1% |
Q4 2021 | $18,981,000 | -13.0% | 160,527 | -1.3% | 3.46% | +2.2% |
Q3 2021 | $21,815,000 | +212.9% | 162,620 | +26.9% | 3.38% | +462.1% |
Q4 2020 | $6,972,000 | – | 128,162 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |